TD Cowen analyst Bryan Bergin lowered the firm’s price target on Endava to $42 from $46 and keeps a Buy rating on the shares. The firm said 3Q was a mixed bag andthe company revised its 4Q organic view marking the low-end of its prior guide. Still, a message of stability and a more conservative guide posture were well-received.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DAVA:
Questions or Comments about the article? Write to editor@tipranks.com